Member Info for ratcliffewriter

You can always spot a ramping crew member by their continuous fishing for details on those who don't toe the line. What sex is nomlungu? What is RW's age? Do you own shares? Are you planning to buy? Where does P9 live?

Data is valuable and can be used, keep fishing lads, it's your best way of gaining information to attack.

Why are your crew so keen to know details that have no relevance whatsoever to any investment decisions?

Uxm - would it make a difference to your attitude if you knew? Or is your reply just an attempt at distraction from pertinent facts?

TWC - You need to read what was actually posted and understand it before you reply. Your comment 'I presume you can't name the posters you accuse of having criminal pasts then?' shows you have not read or understood what I put.

My investments and all decisions around them are between me and my stockbroker, for obvious reasons.

The last time I openly considered investing here it was at 1.3p from memory, and I was advised to get in because 'after all, 201 is nailed on, funding is secure with the gruesome twosome gone, and it can't go much lower.' I didn't invest and shortly thereafter there was a 125/1 consolidation.

Nom - there's more evidence for that than P9's address, and it's a much more urgent matter to be addressed too. That and the criminal past of some of the rampers...

PM 2022 - just for accuracy, the allegation 'It has been widely claimed he lives a few doors away from our CEO' is about as accurate as someone talking repeatedly about your convictions for flashing in your local park, and (assuming it's untrue of course) repeating it with a bunch of mates on here until newcomers think there must be some truth in it. You'd be better off talking about the peer reviews of 201, so fill us in on those if you would please. It might be a little more constructive and nothing breach of posting rules.

I suspect the only thing that's rotten is the smell of fish..

A peer review by a man who is one of the company's biggest shareholders is hardly likely to be damning, and I seem to remember when I asked him if there were any peer reviews of 201 the answer was no. Not one in three years despite them being promised in the RNS at that time.

But his timeline layout for a placing being necessary seems very plausible even if the merger does actually secure any funding, and be honest about 201 - no update in 3 years, not even a peer-reviewed document (which was promised) on a trial of just 12 patients, only one of which showed any real change. Have you considered P9 might have a point?

PM2022 - you say 'Porky is only here because he lost all his money on 4D and is bitter with VAL' - if you actually did lose all your money on 4D wouldn't you be likely to be bitter towards 4D?

On 'the other board' - wudashudacuda: Only have a small holding here but been keeping track of recent developments and confident the 201 deal is about to complete.

Time to top up. I just wish I had more funds available.

Be fair, that's one of the classic ramper posts if ever there was.

Https://i.pinimg.com/originals/62/66/48/626648255dcb08b2be12564ab53c4f11.jpg

As some may know I've followed this for a while and was strongly urged to invest at 1.3p just ahead of a 125/1 consolidation, so obviously glad I didn't. So just wondering what the latest data from 201 is - the results were 3 years ago and promised peer reviewed papers, but none have appeared. Any suggestions here?

An anagram of Ken Sorensen is 'erk nonsense', but that's irrelevant too, unless anagrams have taken over from RNSs.

On the 'other board' Jason Pugh says 'According to the morning star dated Oct 5th 2023 2pm GMT+1 hrs.

“EUDA health holdings Ltd enters into letter of intent for proposed merger with Theoremrx inc” on para 9 it stated Theormrx management have raised 1 billion dollars in the past. Thats one with nine zeros after it.'

All very commendable, but it does make me wonder why, if they can raise a billion dollars with implied ease, what's stopping them bunging a paltry 1.3 million quid to valirx if the business case is allegedly so strong?

P.I. - don't quite follow the comment 'It was painful to see my investment crushed (>400%)'

Surely once you are down 100% then that's zero, end of story isn't it?

Raypointer - I agree it would be better to discuss the science rather than expend enormous effort trying to trash a dissenting opinion, but then it's nearly 3 years since 201's final results came out. Maybe it's been talked to exhaustion.

That last trade is at 10.243 which is below the mid point of bid/ask. Is it possible it's a forward sell ahead of a placing? Or are you confident it's a low buy on a falling bid?

"Could it be the company is well aware of the reason for the consecutive leaps?"

They may well be aware, but it depends very much what it is they're aware of.....